Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAIDA 2% w/w.
http://ift.tt/1dBnqF1
http://ift.tt/1dBnqF1
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment